Kyoto University Innovation Capital Corporation (Head office: Sakyo-ku, Kyoto; Representative Director: Koji Murota; hereinafter "KyotoiCAPInnovation Kyoto, Inc.2016Investment Limited Liability Partnership ("theKYOTO–iCAP("No. 1 Fund") is pleased to announce that the U.S.Drawbridge Health Inc.(Headquarters: California, President:Lee MacCrackenHereinafter referred to as "Drawbridge Health(hereinafter referred to as "the Company"). As a result of this investmentDrawbridge HealthThe company will attempt to expand its revolutionary new blood collection technology worldwide.

In making this investment, the Company has decided to use the following two investment methodsDrawbridge Healthregional Chinese god of the earth (or a village built in its honour)CEO(at sentence-end, falling tone) indicates a confident conclusionLee MacCrackenhas made the following comments

Koji Murota
KyotoiCAPHa,DrawbridgeHealthThe Company highly evaluated the potential market size of the new technology developed by the company and its policy to contribute to people's health through health monitoring. We are also looking forward toDrawbridge HealthWe are delighted to have the opportunity to contribute to the health of people in Japan and around the world by working on the development of this technology in collaboration with the company and Kyoto University.

Lee MacCracken
."DrawbridgeHealthThe company is located in KyotoiCAPWe are very honored to collaborate with Kyoto University, one of the top research institutions in Japan and Asia. We sincerely appreciate the opportunity to contribute to the health of Japanese patients and people through the development of our novel blood collection technology in Japan.
Prior to the Investment AgreementDrawbridgeHealthLtd. has decided to conduct a joint research project with the Department of Diabetes, Endocrinology and Nutrition, Kyoto University Hospital. Professor Nobuya Inagaki and Assistant Professor Kaori Ikeda of the same department,Drawbridge HealthWe will lead the joint research with the company.

periodDrawbridge HealthInc.About
Drawbridge HealthThe company is,GE VenturesandGEHealthcareA privately held U.S. healthcare technology company founded by Dr. David H. Harris, Ph. The company integrates proprietary engineering and chemical technologies to develop medical devices that reduce discomfort during blood collection and preserve blood stably after collection, with the goal of creating a world in which a variety of personal diagnostics are possible anytime, anywhere. For more information,Home Pagefor more information.